Renal replacement therapy does have impact on beta-lactam clearance.
作者信息
Yu Zhenwei
机构信息
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 3Rd East Qingchun Road, Handzhou, China.
出版信息
Ann Intensive Care. 2023 Jun 6;13(1):48. doi: 10.1186/s13613-023-01148-3.
Abstract
摘要
相似文献
1
Renal replacement therapy does have impact on beta-lactam clearance.
Ann Intensive Care. 2023 Jun 6;13(1):48. doi: 10.1186/s13613-023-01148-3.
2
β-lactam antibiotic concentrations during continuous renal replacement therapy.
Crit Care. 2014 May 22;18(3):R105. doi: 10.1186/cc13886.
3
Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
Int J Antimicrob Agents. 2017 May;49(5):589-594. doi: 10.1016/j.ijantimicag.2017.01.009. Epub 2017 Mar 21.
4
Pharmacokinetic/Pharmacodynamic Considerations of Beta-Lactam Antibiotics in Adult Critically Ill Patients.
Curr Infect Dis Rep. 2018 Apr 4;20(5):9. doi: 10.1007/s11908-018-0613-1.
5
Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units.
BMC Nephrol. 2022 Jan 29;23(1):48. doi: 10.1186/s12882-022-02678-x.
6
Impact of renal replacement therapy strategy on beta-lactam plasma concentrations: the BETAKIKI study-an ancillary study of a randomized controlled trial.
Ann Intensive Care. 2023 Feb 25;13(1):11. doi: 10.1186/s13613-023-01105-0.
7
Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.
Int J Antimicrob Agents. 2017 May;49(5):624-630. doi: 10.1016/j.ijantimicag.2016.12.022. Epub 2017 Mar 9.
8
Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base.
Curr Opin Infect Dis. 2020 Dec;33(6):501-510. doi: 10.1097/QCO.0000000000000681.
9
β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance.
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.02534-17. Print 2018 Sep.
10
Pharmacokinetic variability of beta-lactams in critically ill patients: A narrative review.
Anaesth Crit Care Pain Med. 2020 Feb;39(1):87-109. doi: 10.1016/j.accpm.2019.07.016. Epub 2019 Sep 9.
引用本文的文献
1
Serum Concentration at 24 h With Intensive Beta-Lactam Therapy in Sepsis and Septic Shock: A Prospective Study: Beta-Lactam Blood Levels in Sepsis.
Crit Care Res Pract. 2024 Oct 21;2024:9757792. doi: 10.1155/2024/9757792. eCollection 2024.
本文引用的文献
1
Impact of renal replacement therapy strategy on beta-lactam plasma concentrations: the BETAKIKI study-an ancillary study of a randomized controlled trial.
Ann Intensive Care. 2023 Feb 25;13(1):11. doi: 10.1186/s13613-023-01105-0.
2
Target attainment and pharmacokinetics of cefotaxime in critically ill patients undergoing continuous kidney replacement therapy.
J Antimicrob Chemother. 2022 Nov 28;77(12):3421-3426. doi: 10.1093/jac/dkac334.
3
Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis.
J Clin Pharm Ther. 2022 Aug;47(8):1091-1102. doi: 10.1111/jcpt.13657. Epub 2022 Mar 29.
4
Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.
Front Pharmacol. 2020 May 29;11:786. doi: 10.3389/fphar.2020.00786. eCollection 2020.
5
Pharmacokinetic variability of beta-lactams in critically ill patients: A narrative review.
Anaesth Crit Care Pain Med. 2020 Feb;39(1):87-109. doi: 10.1016/j.accpm.2019.07.016. Epub 2019 Sep 9.
Zotero 插件